-
-
-
-
-
-
-
Soleno Therapeutics (SLNO) Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Soleno Therapeutics Inc. (SLNO)
-
-
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

